3. To enhance the communication aspects, CDSCO should ensure that the industry representatives, and other stakeholders have easy and open access to all the relevant regulatory information and are educated about the drug regulatory requirements, process involved in new drug development. 4. Similarly, CDSCO meetings including Pre-submission/ Post–submission/SEC meetings should be held as per the laid down procedures efficiently to facilitate the development of safe and effective new drugs in the country.